Financhill
Back

Protagonist Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
44

PTGX
Protagonist Therapeutics

Last Price:
47.60
Seasonality Move:
18.58%
Sell
45

NBY
NovaBay Pharmaceuticals

Last Price:
0.73
Seasonality Move:
-8.12%
Sell
44
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $45.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.76
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: 154951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.55 - 47.39) Sell
Bollinger Bands (100): (35.98 - 45.9) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 62.96 Buy
Chaikin Money Flow: -5249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.73) Buy
Bollinger Bands (100): (0.3 - 1.8) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.09 Sell
20-day SMA: 46.37 Sell
50-day SMA: 45.14 Buy
200-day SMA: 34.63 Buy
8-day EMA: 46.69 Sell
20-day EMA: 46.38 Sell
50-day EMA: 44.64 Buy
200-day EMA: 35.99 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.69 Buy
20-day SMA: 0.64 Buy
50-day SMA: 0.6 Buy
200-day SMA: 2.64 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.67 Buy
50-day EMA: 0.75 Buy
200-day EMA: 6.24 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):